GRTX - Galera Therapeutics Inc
Previous close
0.0655
0 0%
Share volume: 4,041,044
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.07
0.00
0.00%
Summary score
22%
Profitability
25%
Dept financing
13%
Liquidity
50%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 31-Dec-2015 - 31-Dec-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-40.84%
Return on assets
-14.61%
Return on sales
0%
Return on invested capital
754.13%
Total debt ratio
54.58%
Debt ratio change over timeo
-0.96%
Current Ratio
10.04%
Quick Ratio
0%
Cash Position Ratio
1.81%
Short-term ratios 31-Dec-2018 - 31-Dec-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-40.84%
Return on assets
-14.61%
Return on sales
0%
Return on invested capital
754.13%
Total debt ratio
54.58%
Debt ratio change over timeo
-0.96%
Current Ratio
10.04%
Quick Ratio
0%
Cash Position Ratio
1.81%
Last quarter ratios 31-Dec-2019
The data are presented for the financials results of the last quarter.
Return on equity
-25.39%
Return on assets
-13.1%
Return on sales
0%
Return on invested capital
454.48%
Total debt ratio
43.58%
Debt ratio change over time
-0.96%
Current Ratio
12.13%
Quick Ratio
0%
Cash Position Ratio
1.89%
Performance ratios (change over 4 years) 31-Dec-2015 - 31-Dec-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-102.41%
Return on assets
-101.24%
Return on sales
0%
Return on invested capital
-56.87%
Total debt ratio
-95.86%
Debt ratio change over time
-0.96%
Current Ratio
0.15%
Quick Ratio
0%
Cash Position Ratio
-0.82%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | GRTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -40.84% | 3.38% | 10.1% | 6.09% |
| Return on assets | -14.61% | 3.79% | 3.51% | 5.38% |
| Return on sales | 0% | 33.46% | 42.92% | 33.01% |
| Return on invested capital | 754.13% | 4.88% | 8.3% | 11.96% |
| Profitability | 25% | 46% | 67% | 60% |
| Total debt ratio | 54.58% | 100.22% | 71.21% | 29.5% |
| Debt ratio change over time | -0.96% | 14.95% | 5.12% | 1.7% |
| Dept financing | 14% | 50% | 26% | 10% |
| Current Ratio | 10.04% | 1.56% | 2.5% | 4.04% |
| Quick Ratio | 0% | 1.45% | 2.22% | 3.29% |
| Cash Position Ratio | 1.81% | 0.97% | 0.66% | 1.72% |
| Liquididy | 50% | 22% | 42% | 48% |
| Short-term ratios | GRTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -40.84% | -24.18% | 18.55% | 5.09% |
| Return on assets | -14.61% | 4.92% | 3.95% | 4% |
| Return on sales | 0% | 37.6% | 41.32% | 27.89% |
| Return on invested capital | 754.13% | 7.93% | 10.38% | 10.86% |
| Profitability | 25% | 48% | 70% | 44% |
| Total debt ratio | 54.58% | 112.95% | 82.58% | 25.55% |
| Debt ratio change over time | -0.96% | 16.62% | 5.88% | 2.04% |
| Dept financing | 12% | 50% | 27% | 9% |
| Current Ratio | 10.04% | 1.56% | 2.5% | 4.04% |
| Quick Ratio | 0% | 1.45% | 2.22% | 3.29% |
| Cash Position Ratio | 1.81% | 0.97% | 0.66% | 1.72% |
| Liquididy | 50% | 28% | 32% | 59% |